We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

662 hedge funds and large institutions have $3.56B invested in iShares US Medical Devices ETF in 2021 Q4 according to their latest regulatory filings, with 128 funds opening new positions, 231 increasing their positions, 188 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 128 | Existing positions closed: 32

23% more repeat investments, than reductions

Existing positions increased: 231 | Existing positions reduced: 188

22% more funds holding in top 10

Funds holding in top 10: 2328 (+5)

15% more funds holding

Funds holding: 574662 (+88)

13% more capital invested

Capital invested by funds: $3.14B → $3.56B (+$419M)

2.06% more ownership

Funds ownership: 37.27%39.33% (+2.1%)

9% more call options, than puts

Call options by funds: $13.7M | Put options by funds: $12.5M

Holders
662
Holders Change
+88
Holders Change %
+15.33%
% of All Funds
10.19%
Holding in Top 10
28
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+21.74%
% of All Funds
0.43%
New
128
Increased
231
Reduced
188
Closed
32
Calls
$13.7M
Puts
$12.5M
Net Calls
+$1.12M
Net Calls Change
+$114K
Name Holding Trade Value Shares
Change
Change in
Stake
Tudor Investment Corp
326
Tudor Investment Corp
Connecticut
$750K +$730K +11,397 New
HFA
327
High Falls Advisors
New York
$747K +$29.6K +463 +4%
FHA
328
First Horizon Advisors
Tennessee
$746K -$63.8K -997 -8%
FCA
329
FLC Capital Advisors
California
$736K -$1.03M -16,138 -59%
LWP
330
Legacy Wealth Planning
Nevada
$736K -$19.2K -300 -3%
Koshinski Asset Management
331
Koshinski Asset Management
Illinois
$719K +$2.24K +35 +0.3%
PWW
332
Pettyjohn Wood & White
Virginia
$714K -$41.6K -650 -6%
MFA
333
Mayflower Financial Advisors
Massachusetts
$713K -$204K -3,183 -23%
AWAG
334
ARS Wealth Advisors Group
Florida
$711K -$384 -6 -0.1%
MSWMA
335
Market Street Wealth Management Advisors
Indiana
$709K -$191K -2,982 -22%
SA
336
Strategic Advisors
New York
$706K -$73.7K -1,152 -10%
AWA
337
Arete Wealth Advisors
Illinois
$699K -$4.29K -67 -0.6%
OCM
338
One Capital Management
California
$687K +$669K +10,446 New
OGC
339
Oak Grove Capital
New Hampshire
$686K -$60.9K -952 -8%
VWA
340
V Wealth Advisors
Kansas
$666K -$7.68K -120 -1%
M&T Bank
341
M&T Bank
New York
$661K -$36.9K -576 -5%
WG
342
Welch Group
Alabama
$658K
MSAM
343
Moloney Securities Asset Management
Missouri
$653K -$14.7K -230 -2%
MFG
344
Magnus Financial Group
New York
$644K +$384 +6 +0.1%
CCA
345
Cadent Capital Advisors
Oklahoma
$644K +$768 +12 +0.1%
PWA
346
PCG Wealth Advisors
Kansas
$639K +$618K +9,649 New
SAM
347
Strategy Asset Managers
California
$637K -$164K -2,557 -21%
KWS
348
Keystone Wealth Services
California
$636K +$618K +9,652 New
VAM
349
Vienna Asset Management
California
$636K +$618K +9,661 New
CRWM
350
Castle Rock Wealth Management
California
$635K -$2.27M -35,519 -77%

IHI Hedge Fund Activity: Q4 2021 in Review

662 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q4 2021, worth a combined $3.56B — up 13% from $3.14B a quarter earlier.

Buyers outnumbered sellers: 128 funds opened new IHI positions and 32 closed out — a net gain of 96 holders — while 231 added to existing stakes and 188 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $36.3M. The largest seller was Marks Wealth, exiting entirely with an estimated $33.2M sold.

  • 662 institutional investors held iShares US Medical Devices ETF (IHI) as of Q4 2021, up from 574 in Q3 2021.
  • Funds reported $3.56B of iShares US Medical Devices ETF stock for Q4 2021, up 13% quarter-over-quarter.
  • 128 funds opened new iShares US Medical Devices ETF positions in Q4 2021 and 32 closed out, a net change of +96 holders.
  • The largest iShares US Medical Devices ETF buyer in Q4 2021 was Morgan Stanley, an estimated $36.3M added.
  • The largest iShares US Medical Devices ETF seller in Q4 2021 was Marks Wealth, an estimated $33.2M sold.

Based on aggregated 13F filings for Q4 2021.